A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial
B. I. ERIKSSON, O. E. DAHL, H. R. BÜLLER, R. HETTIARACHCHI, N. ROSENCHER, M-L. BRAVO, L. AHNFELT, F. PIOVELLA, J. STANGIER, P. KÄLEBO, P. REILLY, FOR THE BISTRO II STUDY GROUPVolume:
3
Year:
2005
Language:
english
Pages:
9
DOI:
10.1111/j.1538-7836.2004.01100.x
File:
PDF, 172 KB
english, 2005